Dolby Laboratories, Inc. (NYSE:DLB) Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 12.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,592 shares of the electronics maker’s stock after acquiring an additional 932 shares during the period. Quantinno Capital Management LP’s holdings in Dolby Laboratories were worth $658,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of DLB. Cetera Advisors LLC purchased a new stake in shares of Dolby Laboratories during the 1st quarter valued at $225,000. SG Americas Securities LLC purchased a new stake in Dolby Laboratories during the second quarter valued at about $1,157,000. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Dolby Laboratories by 9.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,861 shares of the electronics maker’s stock worth $306,000 after purchasing an additional 344 shares during the period. Envestnet Portfolio Solutions Inc. grew its holdings in shares of Dolby Laboratories by 4.0% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 9,536 shares of the electronics maker’s stock worth $756,000 after purchasing an additional 363 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in Dolby Laboratories by 73.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 44,229 shares of the electronics maker’s stock worth $3,504,000 after purchasing an additional 18,760 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on DLB shares. Rosenblatt Securities boosted their price objective on shares of Dolby Laboratories from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Wednesday, November 20th. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th. Finally, Barrington Research reissued an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Wednesday, November 20th.

Dolby Laboratories Stock Down 1.3 %

NYSE DLB opened at $79.18 on Friday. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.28. The business has a 50 day moving average price of $75.86 and a two-hundred day moving average price of $75.77. The stock has a market cap of $7.56 billion, a PE ratio of 29.22 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.67%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date was Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.71%.

Insider Buying and Selling

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at $6,205,400.52. The trade was a 25.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total value of $841,890.00. Following the transaction, the chief accounting officer now owns 24,364 shares of the company’s stock, valued at approximately $1,953,505.52. This trade represents a 30.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 152,091 shares of company stock valued at $12,027,697 in the last quarter. Company insiders own 39.54% of the company’s stock.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.